INTERSTITIAL LUNG DISEASE: RETROSPECTIVE STUDY OF THE PROGNOSTIC IMPACT OF ACUTE EXACERBATIONS

被引:0
|
作者
Pacheco, Joana M. [1 ]
Santos, Ana I. [1 ]
Catarata, Joana [2 ]
Freitas, Sara [1 ]
机构
[1] Coimbra Hosp & Univ Ctr, Pulmonol Dept, Mota Pinto,3004-56, Coimbra, Portugal
[2] Braga Hosp, Pulmonol Dept, Braga, Portugal
关键词
KEY WORDS: interstitial lung disease; pulmonary fibrosis; acute exacerbation;
D O I
10.36141/svdld.v41i4.15198
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Interstitial lung diseases have high mortality associated with hospitalization for decompensation. There are doubts about the factors involved in the progression of fibrosis, for example the role played by acute exacerbations. With this work, the authors intend to analyze whether there are predictive parameters of mortality related to exacerbations. Methods: A retrospective study was carried out of patients admitted to the Pulmonology department of Coimbra University Hospital Center for exacerbation of fibrosing lung disease between January 2019 and December 2020. These were classified as: idiopathic pulmonary fibrosis (IPF), fibrosing hypersensivity pneumonitis (FHP) and other fibrosing lung diseases. Statistical analysis was performed using SPSS 26.0 considering statistically significant p<0.05 values. Results: The results show that IPF is associated with longer hospital stay in relation to fibrosing HP and other fibrosing lung diseases mean of 20.93 days (95% CI: 14.69-27.18) vs 11.8 days (95% CI: 1.05-17.22, p=0.023) vs 12.23 days (95% CI: 2.06-15.34, p=0.007), respectively. Regarding mortality, there was no difference between IPF, PH and other fibrosing diseases (p=0.631). Conclusion: This study demonstrated that IPF, compared to PH and other fibrosing diseases, is associated with longer hospital stays, probably due to its progressive course despite the institution of corticosteroid therapy. As shown in previous studies, it was concluded that there is no difference in terms of mortality between IPF exacerbations and other forms of fibrosing lung disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Survival of Patients with Acute Exacerbations of Rheumatoid Arthritis Associated Interstitial Lung Disease
    Blumhof, S.
    Danila, M.
    Sun, D.
    Valentine, V. G.
    Luckhardt, T.
    De Andrade, J. A.
    Bridges, S.
    Duncan, S. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Prognostic Analysis of Pneumocystis Jirovecii Pneumonia in Interstitial Lung Disease Patients: A Retrospective Clinical Study
    Sun, Yuxin
    Shao, Chi
    Huang, Hui
    Chen, Ruxuan
    Xu, Kai
    Li, Mei
    Zhang, Xin
    Xu, Zuojun
    DIAGNOSTICS, 2022, 12 (12)
  • [23] Prevalence and Prognostic Impact of Physical Frailty in Interstitial Lung Disease
    Farooqi, M.
    O'Hoski, S.
    Goodwin, S.
    Makhdami, N.
    Aziz, A.
    Cox, G. P.
    Kolb, M. R.
    Beauchamp, M.
    Wald, J.
    Ryerson, C.
    Hambly, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Prognostic Significance of Autoantibody Positivity in Interstitial Lung Disease: A Retrospective Case-Control Study
    Kampolis, Christos F.
    Venetsanopoulou, Aliki I.
    Karakontaki, Fotini
    Polychronopoulos, Vlassis
    Vlachoyiannopoulos, Panayiotis G.
    Tzioufas, Athanasios G.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [25] Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer
    Ozawa, Yuichi
    Abe, Takefumi
    Omae, Minako
    Matsui, Takashi
    Kato, Masato
    Hasegawa, Hirotsugu
    Enomoto, Yasunori
    Ishihara, Takeaki
    Inui, Naoki
    Yamada, Kazunari
    Yokomura, Koshi
    Suda, Takafumi
    PLOS ONE, 2015, 10 (10):
  • [26] Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study
    Farooqi, Mohammed A. Malik
    O'Hoski, Sachi
    Goodwin, Sarah
    Makhdami, Nima
    Aziz, Afia
    Cox, Gerard
    Wald, Joshua
    Ryerson, Christopher J.
    Beauchamp, Marla K.
    Hambly, Nathan
    Kolb, Martin
    RESPIROLOGY, 2021, 26 (07) : 683 - 689
  • [27] Recurrent Acute Exacerbations of Fibrotic Interstitial Lung Diseases
    Suzuki, A.
    Kondoh, Y.
    Brown, K. K.
    Kimura, T.
    Kataoka, K.
    Matsuda, T.
    Yokoyama, T.
    Ando, M.
    Hashimoto, N.
    Sakamoto, K.
    Hasegawa, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [28] Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
    Drakopanagiotakis, Fotios
    Markart, Philipp
    Steiropoulos, Paschalis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [29] A pilot study of telemonitoring to detect acute exacerbations in fibrosing interstitial lung diseases
    Fu, Hongyan
    Chen, Juan
    Jia, Yuanyuan
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Physiological responses to functional exercise capacity in interstitial lung disease patients with acute exacerbations
    Ugras, Zeynep Pelin
    Camcioglu, Burcu
    Guclu, Meral Bosnak
    Karadalli, Muserrefe Nur
    Kokturk, Nurdan
    Turktas, Haluk
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46